Creative Financial Designs’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-13
Closed -$272 – 2022
2025
Q1
$272 Hold
13
– – ﹤0.01% 1960
2024
Q4
$308 Hold
13
– – ﹤0.01% 1747
2024
Q3
$335 Hold
13
– – ﹤0.01% 1637
2024
Q2
$307 Hold
13
– – ﹤0.01% 1596
2024
Q1
$376 Hold
13
– – ﹤0.01% 1606
2023
Q4
$429 Sell
13
-1,040
-99% -$28.3K ﹤0.01% 1545
2023
Q3
$29.3K Hold
1,053
– – ﹤0.01% 762
2023
Q2
$35.9K Hold
1,053
– – ﹤0.01% 715
2023
Q1
$31.7K Sell
1,053
-51
-5% -$1.58K ﹤0.01% 694
2022
Q4
$31.2K Hold
1,104
– – ﹤0.01% 659
2022
Q3
$36K Hold
1,104
– – 0.01% 609
2022
Q2
$35K Sell
1,104
-75
-6% -$2.62K 0.01% 612
2022
Q1
$54K Sell
1,179
-45
-4% -$2.15K 0.01% 554
2021
Q4
$75K Sell
1,224
-148
-11% -$10.2K 0.01% 494
2021
Q3
$102K Buy
1,372
+721
+111% +$60.5K 0.02% 439
2021
Q2
$60K Hold
651
– – 0.01% 553
2021
Q1
$58K Buy
651
+11
+2% +$1.09K 0.01% 526
2020
Q4
$60K Buy
640
+300
+88% +$23.9K 0.01% 469
2020
Q3
$22K Buy
340
+240
+240% +$14.1K 0.01% 633
2020
Q2
$5K Buy
+100
New +$4.29K ﹤0.01% 861

Other funds holding ARKG

Creative Financial Designs's ARKG Position: Q2 2025 in Review

Creative Financial Designs sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2025, closing a stake of 13 shares — an estimated $272 sold.

Creative Financial Designs first reported a position in ARKG in Q2 2020 and held it in 20 quarters. The position peaked at $102K in Q3 2021. 216 funds tracked by Wall St. Rank hold ARKG as of Q2 2025.

  • Creative Financial Designs reported no remaining ARK Genomic Revolution ETF position as of Q2 2025 after selling out during the quarter.
  • Creative Financial Designs sold 13 ARK Genomic Revolution ETF shares in Q2 2025, an estimated $272.
  • Creative Financial Designs first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 20 quarters.
  • Creative Financial Designs's ARK Genomic Revolution ETF position peaked at $102K in Q3 2021.
  • 216 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2025.

Based on Creative Financial Designs's 13F filing for Q2 2025, filed 4 Aug 2025.